Recruiting Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors NCT07071103 Conditions Digestive System Diseases, Digestive System Neoplasms, Drug Resistance, +17 more Locations Cancer Hospital, Shantou University Medical College — Shantou, Guangdong, China View Trial Details
Not Yet Recruiting Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer NCT07076836 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more Locations West China Hospital — Chengdu, Sichuan, China View Trial Details
Not Yet Recruiting SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma NCT06538935 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more Locations Not specified View Trial Details
Completed Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors NCT06076135 Conditions Immune Checkpoint Blockade, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +6 more Locations Cancer Hospital, Shantou University Medical College — Shantou, Guangdong, China View Trial Details
Completed The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma NCT04997850 Conditions Hepatocellular Carcinoma Non-resectable, Immune Checkpoint Blockade, Transarterial Chemoembolization, +1 more Locations West China Hospital of Sichuan University — Chengdu, Sichuan, China View Trial Details
